Central R&D Center, B&Tech Co., Ltd., Gwangju 61239, Korea.
Department of Food Science and Nutrition, Nambu University, Gwangju 62271, Korea.
Medicina (Kaunas). 2021 Oct 22;57(11):1147. doi: 10.3390/medicina57111147.
This study aimed at investigating the laxative effects of a standardized aqueous extract of H. Lév. on two different constipation rat models. Animal studies were conducted with low-fiber diet-induced and loperamide-induced constipation animal models, and isolated colons were used in ex vivo analysis to determine the changes in colonic motility caused by H. Lév. leaf extract (DPL). The results showed that DPL administration significantly improved certain reduced fecal parameters (number, weight, and water content of the stools) in a both low-fiber diet and loperamide-induced constipation models without adverse effects of diarrhea. The laxative effect of DPL was confirmed to improve the charcoal excretion time upon DPL treatment in a low-fiber diet or loperamide-induced constipation model through gastrointestinal (GI) motility evaluation using the charcoal meal test. In addition, when DPL was administered to RAW264.7 cells and loperamide-induced constipation model rats, the production of prostaglandin E (PGE) increased significantly in cells and tissue. Furthermore, DPL dose-dependently stimulated the spontaneous contractile amplitude and frequency of the isolated rat colon. Although our study did not provide information on the acute or chronic toxicity of DPL, our results demonstrated that DPL can effectively promote defecation frequency and rat colon contraction, providing scientific evidence to support the use of DPL as a therapeutic application. However, further toxicity studies of DPL are needed prior to the initiation of clinical trials and clinical applications.
本研究旨在探讨 Lév. 的标准化水提物对两种不同便秘大鼠模型的通便作用。动物研究采用低纤维饮食诱导和洛哌丁胺诱导的便秘动物模型进行,离体结肠用于体外分析,以确定 Lév. 叶提取物 (DPL) 引起的结肠运动变化。结果表明,DPL 给药可显著改善低纤维饮食和洛哌丁胺诱导的便秘模型中某些减少的粪便参数(粪便数量、重量和含水量),而无腹泻等不良反应。通过炭末试验评估胃肠(GI)运动,证实 DPL 的通便作用可改善低纤维饮食或洛哌丁胺诱导的便秘模型中炭末排泄时间。此外,当 DPL 给予 RAW264.7 细胞和洛哌丁胺诱导的便秘模型大鼠时,细胞和组织中前列腺素 E (PGE) 的产生显著增加。此外,DPL 剂量依赖性地刺激离体大鼠结肠的自发性收缩幅度和频率。虽然本研究未提供 DPL 的急性或慢性毒性信息,但我们的结果表明 DPL 可有效促进排便频率和大鼠结肠收缩,为 DPL 作为治疗应用提供了科学依据。然而,在启动临床试验和临床应用之前,需要对 DPL 的毒性进行进一步研究。